These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17110151)

  • 1. Treatment of systemic lupus erythematosus in 2006.
    Sibilia J
    Joint Bone Spine; 2006 Dec; 73(6):591-8. PubMed ID: 17110151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic lupus erythematosus: news and therapeutic perspectives].
    Sibilia J; Pasquali JL
    Presse Med; 2008 Mar; 37(3 Pt 2):444-59. PubMed ID: 18242045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement.
    Vitali C; Doria A; Tincani A; Fabbri P; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S17-22. PubMed ID: 9049449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in early clinical development for Systemic Lupus Erythematosus.
    Postal M; Sinicato NA; Appenzeller S; Niewold TB
    Expert Opin Investig Drugs; 2016; 25(5):573-83. PubMed ID: 26950689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É
    Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New biologic therapy for systemic lupus erythematosus.
    Ding HJ; Gordon C
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
    Saison J; Costedoat-Chalumeau N; Maucort-Boulch D; Iwaz J; Marignier R; Cacoub P; Vital-Durand D; Hot A; Tebib J; Aumaitre O; Schleinitz N; Sarrot-Reynauld F; Broussolle C; Sève P
    Lupus; 2015 Jan; 24(1):74-81. PubMed ID: 25117654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity.
    Robak E; Robak T
    Curr Med Chem; 2012; 19(3):438-53. PubMed ID: 22335517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances and prospects in the treatment of systemic lupus erythematosus].
    Ivanova MM; Solov'ev SK
    Ter Arkh; 2009; 81(12):44-7. PubMed ID: 20481048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus diagnosis and management.
    Thong B; Olsen NJ
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i3-i13. PubMed ID: 28013206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs.
    Zhou QS; Hu J; Hu H
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4423-4430. PubMed ID: 29077150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.